APX

1.51%

$1.96 appen limited

APX Charts, page-2979

First 2979 Last

Share
Profile

Follow
Veritas2000

13,580 Posts.

1088

16/10/21

13:33

Post #: 56848225
Share

Originally posted by savvyinvestor: ↑

Happy I picked up another large chunk of Apx at 8.50 last week as I posted on the other thread, based on the bounce to 9.65 this week.

of course all this short term price action really means very little, what we need is the AGM update which will drive the next leg up or down. It’s only 2 months since the HY results so they really need to maintain guidance at the AGM in order to rebuild shareholder trust in their credibility. If they maintain guidance, i think this will stop the bleeding in The sp for now and we can build a new base between $9-11 with a view to hopefully further growth guidance in 2022 at the feb results, which will then drive the next leg up.

my point is that the chart is symptomatic of sentiment, but I only use it to guide my shorter term entry and exit points when adding/ exiting a medium to long term position. I do not trust the chart to decide whether or not to buy or sell, just to guide timing of entry / exit points.

otherwise you are just following (and by definition lagging behind) the crowd).

Apx is one of the only positions I’ve seen go from a Disallowed plus down to now a net slight loss on current holdings (having taken profits on some of my $3 stock on the way up and then added back on the way down at around $20, $13 and $8.50 so overall I’m now slightly in the red. Ordinarily I tend to bias towards adding to my positions as they rise and cutting my positions if they start to head down, fighting actively against loss aversion bias, but i thought Apx was overvalued on the way up so lightened a little, and now I believe it’s intrinsically under valued with a good graham-esque ‘margin of safety’ at 8.50, just as I thought the same of alibaba at HK 135 last week in the midst of evergrande panic and tech wobbles.

Expand

Many thanks for such an informed post and may I say your sentiment that "charts tell you when to buy or sell" is something I have long followed, along with "fundamental analysis tells you what to buy"

That is the way to have a future in investing- hence you are a "savyinvestor"

APX Price at posting: $9.65 Sentiment: None Disclosure: Not Held
3 Upvote

0 Great analysis

Reply

Top Stories

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

BUX

Buxton projects new graphite province discovery at WA Narryer play

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

There are more pages in this discussion • 894 more messages in this thread...

First 2979 Last

Add APX (ASX) to my watchlist

(20min delay)
Last $1.96		Change -0.030(1.51%)		Mkt cap ! $439.6M

Open	High	Low	Value	Volume
$1.96	$2.05	$1.90	$16.06M	8.159M

Buyers (Bids)

No.	Vol.	Price($)
5	70913	$1.96

Sellers (Offers)

Price($)	Vol.	No.
$1.97	5000	1

View Market Depth

No.	Vol.	Price($)
5	70913	1.960
2	4510	1.955
9	182035	1.950
3	5900	1.940
1	15000	1.935

Price($)	Vol.	No.
1.970	5000	1
1.975	26192	2
1.980	4800	1
1.985	877	1
1.990	10000	1

Last trade - 16.10pm 04/10/2024 (20 minute delay)

APX (ASX) Chart

APX Charts, page-2979

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

BCI reaches close of funding facility for salt-first part of Mardie project

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Buxton projects new graphite province discovery at WA Narryer play

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

APX Charts, page-2979

Top Stories

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

BCI reaches close of funding facility for salt-first part of Mardie project

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Buxton projects new graphite province discovery at WA Narryer play

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News